Cardiff Oncology, Inc.
CRDF- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213037
In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Cardiff Oncology, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 115 | 1 | 112 | −2 |
| Shares | 28.7M | 806 | 25.2M | −3.45M (−12.0%) |
| Value | $90.3M | $2.54K | $51.9M | −$38.4M (−42.5%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Cardiff Oncology, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 161,928 | $333.6K | 0.00% |
| Cubist Systematic Strategies, LLC | 88,903 | $183.1K | 0.00% |
| HB Wealth Management, LLC | 71,939 | $148.2K | 0.00% |
| Rockefeller Capital Management L.P. | 62,500 | $128.8K | 0.00% |
| Post Resch Tallon Group Inc. | 22,538 | $46.4K | 0.04% |
| Citadel Advisors LLC | 22,365 | $46.1K | 0.00% |
| Readystate Asset Management LP | 21,024 | $43.3K | 0.00% |
| Two Sigma Securities, LLC | 16,528 | $34.0K | 0.01% |
| HRT Financial LP | 14,335 | $29.0K | 0.00% |
| Jeppson Wealth Management, LLC | 12,001 | $24.7K | 0.01% |
| Quarry LP | 11,135 | $22.9K | 0.01% |
| Proactive Wealth Strategies LLC | 10,000 | $20.6K | 0.01% |
| Hurley Capital, LLC | 7,100 | $14.6K | 0.01% |
| Russell Investments Group, Ltd. | 5,135 | $10.6K | 0.00% |
| CIBC Private Wealth Group, LLC | 3,000 | $6.18K | 0.00% |
| Optiver Holding B.V. | 498 | $1.03K | 0.00% |
| Farther Finance Advisors, LLC | 322 | $663 | 0.00% |
| The PNC Financial Services Group, Inc. | 236 | $486 | 0.00% |
| Colony Group, LLC | 5,185 | – | – |
Sold out (21)
Institutions that held Cardiff Oncology, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 1,423,000 | $4.48M |
| Marshall Wace, LLP | 298,715 | $941.0K |
| Blackstone Group Inc. | 158,330 | $498.7K |
| Gsa Capital Partners LLP | 129,731 | $409.0K |
| Jacobs Levy Equity Management, Inc | 92,269 | $290.6K |
| Atom Investors LP | 71,051 | $223.8K |
| MetLife Investment Management | 36,363 | $114.5K |
| Los Angeles Capital Management LLC | 24,655 | $77.7K |
| Steel Peak Wealth Management LLC | 22,800 | $71.8K |
| Graham Capital Management, L.P. | 18,718 | $59.0K |
| Mariner, LLC | 18,149 | $57.2K |
| Denver Wealth Management, Inc. | 15,235 | $48.0K |
| Wolverine Trading, LLC | 14,573 | $45.9K |
| Castleview Partners, LLC | 13,995 | $44.1K |
| Engineers Gate Manager LP | 13,585 | $42.8K |
| Baader Bank INC | 10,022 | $19.5K |
| Dauntless Investment Group, LLC | 5,000 | $15.8K |
| Group One Trading, L.P. | 2,863 | $9.02K |
| Larson Financial Group LLC | 328 | $1.03K |
| Allworth Financial LP | 100 | $315 |
| IFP Advisors, Inc | 0 | $103 |
Not filed for Q3 2025 yet (1)
Institutions that held Cardiff Oncology, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Moser Wealth Advisors, LLC | 806 | $2.54K |